Drug discovery with industry standards
Validated therapeutic targets resulting from basic research or test systems for known pathological processes typically provide the starting point for drug discovery collaborations with the LDC. However, projects can also enter at more advanced levels, e.g. at the screening or hit-to-lead stage. What all projects should have in common is an outstanding level of quality and innovativeness, high medical need and commercial potential. Moreover, the LDC attaches great importance to a ‘cultural fit’ with its partners as it strives for intense and long-term co-operations.
Tailored solutions for innovative projects
LDC services span the full scope of drug discovery from target to lead generation and first characterization in relevant animal models. Depending on the specific needs of individual projects, the teams will operate in flexible structures and integrate external expertise where appropriate. Partners will take advantage of the LDC’s professional approach to project management and industrial drug discovery know-how to obtain first-rate results. Projects are aligned along a solid timeline model with clearly pre-defined milestones and GO/NO-GO decisions.
Throughout the process, the team will place particular emphasize on consolidating and expanding the IP position - a prerequisite for future commercialization. The typical outcome of LDC development efforts are pharmaceutical leads with initial proof-of-concept and comprehensive data packages, that have the best prospects of receiving high valuations in deals with industry.
